These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14508801)

  • 1. Spontaneous rupture of the spleen in AL amyloidosis.
    Oran B; Wright DG; Seldin DC; McAneny D; Skinner M; Sanchorawala V
    Am J Hematol; 2003 Oct; 74(2):131-5. PubMed ID: 14508801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
    Fernández de Larrea C; Cibeira MT; Rovira M; Rosiñol L; Esteve J; Bladé J
    Eur J Haematol; 2008 Feb; 80(2):182-4. PubMed ID: 18081703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atraumatic splenic rupture in amyloidosis.
    Renzulli P; Schoepfer A; Mueller E; Candinas D
    Amyloid; 2009 Mar; 16(1):47-53. PubMed ID: 19291515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
    Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
    Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
    Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of acquired von Willebrand syndrome with AL amyloidosis.
    Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
    Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.
    Taimur S; Nader C; Lloyd-Travaglini C; Seldin DC; Sanchorawala V
    Transpl Infect Dis; 2013 Apr; 15(2):187-94. PubMed ID: 23279695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of autologous stem cell transplantation for nine cases of cardiac amyloidosis].
    Ogura M; Sekine R; Nishiyama S; Abe Y; Iizuka H; Kusaka S; Nakagawa Y; Suzuki K
    Rinsho Ketsueki; 2012 Jul; 53(7):710-5. PubMed ID: 22975774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic amyloidosis: a case report of spontaneous splenic rupture with a review of the pertinent literature.
    Kozicky OJ; Brandt LJ; Lederman M; Milcu M
    Am J Gastroenterol; 1987 Jun; 82(6):582-7. PubMed ID: 3578242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
    Breems DA; Sonneveld P; de Man RA; Leebeek FW
    Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Oran B; Malek K; Sanchorawala V; Wright DG; Quillen K; Finn KT; La Valley M; Skinner M; Seldin DC
    Bone Marrow Transplant; 2005 Mar; 35(6):567-75. PubMed ID: 15665842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
    Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
    Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis.
    Perotti C; Del Fante C; Viarengo G; Perlini S; Vezzoli M; Rodi G; Palo A; Bergamaschi P; Salvaneschi L
    Transfusion; 2005 Nov; 45(11):1729-34. PubMed ID: 16271097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
    Chow LQ; Bahlis N; Russell J; Chaudhry A; Morris D; Brown C; Stewart DA
    Bone Marrow Transplant; 2005 Oct; 36(7):591-6. PubMed ID: 16062177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.
    Sanchorawala V; Seldin DC; Magnani B; Skinner M; Wright DG
    Bone Marrow Transplant; 2005 Oct; 36(7):597-600. PubMed ID: 16044137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic rupture in systemic amyloidosis - case presentation and review of the literature.
    Skok P; Knehtl M; Ceranić D; Glumbić I
    Z Gastroenterol; 2009 Mar; 47(3):292-5. PubMed ID: 19280544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.